title: Intravitreal bevacizumab for neovascular glaucoma.
authors.forename: Jost B
authors.initials: JB
authors.lastname: Jonas
authors.forename: Lidia
authors.initials: L
authors.lastname: Golubkina
authors.forename: Teodosio
authors.initials: T
authors.lastname: Libondi
authors.forename: Florian
authors.initials: F
authors.lastname: Rensch
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015355:Glaucoma, Neovascular / Q000188:drug therapy*; D006801:Humans; D056965:Injections, Intraocular; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab